Cargando…

Dry needling for treating spasticity in multiple sclerosis

[Purpose] The aim of the study is to evaluate the efficacy of dry needling (DN) in the treatment of spasticity in patients with multiple sclerosis (MS). [Participants and Methods] Twelve participants (3 males and 9 females) with MS, with no evidence of a relapse in the last four weeks and with an ED...

Descripción completa

Detalles Bibliográficos
Autores principales: del Pilar Pérez-Trujillo, María, González-Platas, Montserrat, Pérez-Martín, María Yaiza, Revert-Gironés, María Consuelo, González-Platas, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Society of Physical Therapy Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245259/
https://www.ncbi.nlm.nih.gov/pubmed/34219954
http://dx.doi.org/10.1589/jpts.33.505
_version_ 1783716080315793408
author del Pilar Pérez-Trujillo, María
González-Platas, Montserrat
Pérez-Martín, María Yaiza
Revert-Gironés, María Consuelo
González-Platas, Javier
author_facet del Pilar Pérez-Trujillo, María
González-Platas, Montserrat
Pérez-Martín, María Yaiza
Revert-Gironés, María Consuelo
González-Platas, Javier
author_sort del Pilar Pérez-Trujillo, María
collection PubMed
description [Purpose] The aim of the study is to evaluate the efficacy of dry needling (DN) in the treatment of spasticity in patients with multiple sclerosis (MS). [Participants and Methods] Twelve participants (3 males and 9 females) with MS, with no evidence of a relapse in the last four weeks and with an EDSS (Expanded Disability Status Scale) greater than 2.5 points (related with pyramidal score) were recruited. DN was performed in lower limbs for 12 consecutive sessions and evaluated with: PSFS (Penn Spasm Frequency Scale), VAS (visual analogical scale) of spasticity, EDSS (Pyramidal item), Time up and go (TUG), 25 foot, 9hold peg test (9HPT) and the improvement or not in the quality of life (MSQol54) was verified before and after treatment. A follow up visit was carried out to assess improvement. [Results] All patients improved in: VAS scale, EDSS score, quality of life, 9HPT, 25 foot test and TUG and 90% of them showed a decrease in the number of spasms/hour (PSFS). [Conclusion] Dry needling produces positive changes in spasticity in patients with MS and their quality of life, as well as walking capacity and manual dexterity. Therefore, DN should be considered in the treatment of spasticity in patients with MS.
format Online
Article
Text
id pubmed-8245259
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Society of Physical Therapy Science
record_format MEDLINE/PubMed
spelling pubmed-82452592021-07-03 Dry needling for treating spasticity in multiple sclerosis del Pilar Pérez-Trujillo, María González-Platas, Montserrat Pérez-Martín, María Yaiza Revert-Gironés, María Consuelo González-Platas, Javier J Phys Ther Sci Case Study [Purpose] The aim of the study is to evaluate the efficacy of dry needling (DN) in the treatment of spasticity in patients with multiple sclerosis (MS). [Participants and Methods] Twelve participants (3 males and 9 females) with MS, with no evidence of a relapse in the last four weeks and with an EDSS (Expanded Disability Status Scale) greater than 2.5 points (related with pyramidal score) were recruited. DN was performed in lower limbs for 12 consecutive sessions and evaluated with: PSFS (Penn Spasm Frequency Scale), VAS (visual analogical scale) of spasticity, EDSS (Pyramidal item), Time up and go (TUG), 25 foot, 9hold peg test (9HPT) and the improvement or not in the quality of life (MSQol54) was verified before and after treatment. A follow up visit was carried out to assess improvement. [Results] All patients improved in: VAS scale, EDSS score, quality of life, 9HPT, 25 foot test and TUG and 90% of them showed a decrease in the number of spasms/hour (PSFS). [Conclusion] Dry needling produces positive changes in spasticity in patients with MS and their quality of life, as well as walking capacity and manual dexterity. Therefore, DN should be considered in the treatment of spasticity in patients with MS. The Society of Physical Therapy Science 2021-07-01 2021-07 /pmc/articles/PMC8245259/ /pubmed/34219954 http://dx.doi.org/10.1589/jpts.33.505 Text en 2021©by the Society of Physical Therapy Science. Published by IPEC Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Case Study
del Pilar Pérez-Trujillo, María
González-Platas, Montserrat
Pérez-Martín, María Yaiza
Revert-Gironés, María Consuelo
González-Platas, Javier
Dry needling for treating spasticity in multiple sclerosis
title Dry needling for treating spasticity in multiple sclerosis
title_full Dry needling for treating spasticity in multiple sclerosis
title_fullStr Dry needling for treating spasticity in multiple sclerosis
title_full_unstemmed Dry needling for treating spasticity in multiple sclerosis
title_short Dry needling for treating spasticity in multiple sclerosis
title_sort dry needling for treating spasticity in multiple sclerosis
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245259/
https://www.ncbi.nlm.nih.gov/pubmed/34219954
http://dx.doi.org/10.1589/jpts.33.505
work_keys_str_mv AT delpilarpereztrujillomaria dryneedlingfortreatingspasticityinmultiplesclerosis
AT gonzalezplatasmontserrat dryneedlingfortreatingspasticityinmultiplesclerosis
AT perezmartinmariayaiza dryneedlingfortreatingspasticityinmultiplesclerosis
AT revertgironesmariaconsuelo dryneedlingfortreatingspasticityinmultiplesclerosis
AT gonzalezplatasjavier dryneedlingfortreatingspasticityinmultiplesclerosis